Keryx Biopharma (KERX) – Analyst EPS View
-
UPDATE: Morgan Stanley Starts Keryx Biopharmaceuticals (KERX) at Underweight
-
Roth Capital Downgrades Keryx Biopharmaceuticals (KERX) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to KERX Stock Lookup